CD86 and Neonatal sepsis: Asmaa et al.’s study of 30 neonatal sepsis (a total of 60 participates) showed that compared with the control group, CD86 + monocytes in the sepsis group were significantly higher (median 78.4% vs. 24.0%, P < 0.001).